雜志介紹

European Journal Of Pharmaceutical Sciences雜志介紹

《European Journal Of Pharmaceutical Sciences》是一本以English為主的未開放獲取國際優秀期刊，中文名稱歐洲藥學雜志，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.3，最新CiteScore 指數為9.6。

本刊近期中國學者發表的論文主要有：

• Effect of polyethylene glycol 400 on the pharmacokinetics and tissue distribution of baicalin by intravenous injection based on the enzyme activity of UGT1A8/1A9

  Author: Shang, Le-Yuan; Zhou, Ming-Hao; Cao, Si-Yuan; Zhang, Min; Wang, Peng-Jiao; Zhang, Shuo; Meng, Xiao-Xia; Yang, Qi-Mei; Gao, Xiu-Li

• Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

  Author: Luo, Xiaofang; Chen, Huifang; Song, Yannan; Qin, Zuodong; Xu, Lijian; He, Nongyue; Tan, Yimin; Dessie, Wubliker

• Fabrication of betamethasone micro- and nanoparticles using supercritical antisolvent technology: In vitro drug release study and Caco-2 cell cytotoxicity evaluation

  Author: Wang, Xiangxiang; He, Shuang; Wang, Kaiye; Wang, Xin; Yan, Tingyuan; Yan, Tingxuan; Wang, Zhixiang

• Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer

  Author: Zhong, Ming; Chalbatani, Ghanbar Mahmoodi; Deng, Meifang; Li, Qiuyi; Gharagouzloo, Elahe; Hamblin, Michael R.; Suarez, Eloah Rabello; Hu, Lili; Wang, Dingding

英文介紹

European Journal Of Pharmaceutical Sciences雜志英文介紹

The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.

More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.

Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.